Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

“Novavax vaccine trials run in South Africa and the UK indicate that its efficacy in the UK was 89% at least seven days after individuals had received two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people living without HIV.”

via The Conversation
More analysis from COVID-19 Africa Watch: